These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Advances in the Immunogenic Design of HIV-1 Vaccine]. Zhang X; Wang T; Yu X Bing Du Xue Bao; 2016 Jan; 32(1):88-92. PubMed ID: 27295889 [TBL] [Abstract][Full Text] [Related]
3. Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies. Williams WB; Wiehe K; Saunders KO; Haynes BF J Int AIDS Soc; 2021 Nov; 24 Suppl 7(Suppl 7):e25831. PubMed ID: 34806332 [TBL] [Abstract][Full Text] [Related]
4. Targeting broadly neutralizing antibody precursors: a naïve approach to vaccine design. McGuire AT Curr Opin HIV AIDS; 2019 Jul; 14(4):294-301. PubMed ID: 30946041 [TBL] [Abstract][Full Text] [Related]
5. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745 [TBL] [Abstract][Full Text] [Related]
6. Modelling the spread of HIV immune escape mutants in a vaccinated population. Fryer HR; McLean AR PLoS Comput Biol; 2011 Dec; 7(12):e1002289. PubMed ID: 22144883 [TBL] [Abstract][Full Text] [Related]
7. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens. Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626 [TBL] [Abstract][Full Text] [Related]
8. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422 [TBL] [Abstract][Full Text] [Related]
9. Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1. Sather DN; Carbonetti S; Malherbe DC; Pissani F; Stuart AB; Hessell AJ; Gray MD; Mikell I; Kalams SA; Haigwood NL; Stamatatos L J Virol; 2014 Nov; 88(22):12968-81. PubMed ID: 25122781 [TBL] [Abstract][Full Text] [Related]
11. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques. Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847 [TBL] [Abstract][Full Text] [Related]
12. Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model. Page M; Stebbings R; Berry N; Hull R; Ferguson D; Davis L; Duffy L; Elsley W; Hall J; Ham C; Hassall M; Li B; Mee ET; Quartey-Papafio R; Rose NJ; Mathy N; Voss G; Stott EJ; Almond N Retrovirology; 2012 Jul; 9():56. PubMed ID: 22799593 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies. de Taeye SW; Moore JP; Sanders RW Trends Immunol; 2016 Mar; 37(3):221-232. PubMed ID: 26869204 [TBL] [Abstract][Full Text] [Related]
14. Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses. Beltran-Pavez C; Bontjer I; Gonzalez N; Pernas M; Merino-Mansilla A; Olvera A; Miro JM; Brander C; Alcami J; Sanders RW; Sanchez-Merino V; Yuste E J Virol; 2022 Jan; 96(1):e0134321. PubMed ID: 34668778 [TBL] [Abstract][Full Text] [Related]
15. Vaccines and vaccine strategies against HIV. Stratov I; DeRose R; Purcell DF; Kent SJ Curr Drug Targets; 2004 Jan; 5(1):71-88. PubMed ID: 14738219 [TBL] [Abstract][Full Text] [Related]